Initial Experience With the Next-Generation Resolute Onyx Zotarolimus-Eluting Stent in Symptomatic Intracranial Atherosclerotic Disease

Background and Purpose: Intracranial atherosclerotic disease (ICAD) is a common cause of stroke worldwide. Although there are different endovascular options for the treatment of symptomatic ICAD (sICAD), it is still controversial. Herein, we aim to study the safety and efficacy of a new generation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Ameer E., Mohammaden, Mahmoud H., Rabah, Rani Ramsey, Tekle, Wondwossen G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555826/
https://www.ncbi.nlm.nih.gov/pubmed/33101179
http://dx.doi.org/10.3389/fneur.2020.570100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555826/
https://www.ncbi.nlm.nih.gov/pubmed/33101179
http://dx.doi.org/10.3389/fneur.2020.570100

Ejemplares similares